BioSpace News Archive

Marinus Pharmaceuticals, Inc. today provided an update on its clinical and regulatory development activities and reported its financial results for the third quarter ended September 30, 2021.

Sonoma Pharmaceuticals, Inc. announce a renewed and expanded long-term partnership for Singapore, Malaysia, Indonesia and Thailand for multiple indications using Sonoma’s patented Microcyn® Technology.

Repro Med Systems, Inc. today announced its participation in two upcoming conferences, Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and the 33rd Annual Piper Sandler Healthcare Conference.

Karuna Therapeutics, Inc today announced their entry into an exclusive license agreement for the development, manufacturing, and commercialization of KarXT (xanomeline-trospium) in Greater China, including mainland China, Hong Kong, Macau, and Taiwan.

Cybin Inc. today announced that it will report financial results for its second quarter of fiscal 2021 ended September 30, 2021 on Monday, November 15, 2021.

Olema Pharmaceuticals, Inc. today announced that management will participate in two upcoming investor conferences in November.

Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Mereo BioPharma Group plc today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will present at two upcoming investor conferences: Jefferies London Healthcare Conference In-person Fireside Chat, Wednesday, November 17 at 10:00 a.m. Greenwich Mean Time

RNA Disease Diagnostics, Inc. announced today that it has secured an exclusive global license to a rapid ribonucleic acid (“RNA”)-based molecular Lateral Flow Assay

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Monday, November 15th, 2021, at 8:00 a.m. EDT, to report third quarter 2021 financial results and provide business updates.